ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates
Puma Biotechnology PBYI reported first-quarter 2025 adjusted earnings of 10 cents per share, which beat the Zacks Consensus Estimate of 2 cents. In the year-ago quarter, the company had incurred a loss...
Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y
Amarin Corporation AMRN reported a loss of 4 cents per share for the first quarter of 2025, which was significantly narrower than the Zacks Consensus Estimate of a loss of $1.12. The company had reported...
ESPR's Q1 Earnings Miss Estimates, Revenues Beat, Stock Down
Esperion Therapeutics ESPR incurred a loss of 21 cents per share in the first quarter of 2025, which was wider than the Zacks Consensus Estimate of a loss of 18 cents. In the year-ago quarter, Esperion...